Andrew P Rasdal - Net Worth and Insider Trading
Andrew P Rasdal Net Worth
The estimated net worth of Andrew P Rasdal is at least $7 Million dollars as of 2024-04-26. Andrew P Rasdal is the President & CEO of DexCom Inc and owns about 47,104 shares of DexCom Inc (DXCM) stock worth over $7 Million. Andrew P Rasdal is also the Exec Chairman of the Board of Obalon Therapeutics Inc and owns about 25,964 shares of Obalon Therapeutics Inc (OBLN) stock worth over $79,190. Details can be seen in Andrew P Rasdal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew P Rasdal has not made any transactions after 2019-08-06 and currently still holds the listed stock(s).
Transaction Summary of Andrew P Rasdal
Andrew P Rasdal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew P Rasdal owns 3 companies in total, including Obalon Therapeutics Inc (OBLN) , DexCom Inc (DXCM) , and Reshape Lifesciences Inc (RSLS) .
Click here to see the complete history of Andrew P Rasdal’s form 4 insider trades.
Insider Ownership Summary of Andrew P Rasdal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OBLN | Obalon Therapeutics Inc | 2020-06-23 | director & President & CEO & Exec Chairman |
| DXCM | DexCom Inc | 2006-05-02 | director & President and CEO |
| RSLS | Reshape Lifesciences Inc | 2016-10-05 | director & President & CEO |
Andrew P Rasdal Latest Holdings Summary
Andrew P Rasdal currently owns a total of 2 stocks. Among these stocks, Andrew P Rasdal owns 47,104 shares of DexCom Inc (DXCM) as of May 2, 2006, with a value of $7 Million and a weighting of 98.8%. Andrew P Rasdal also owns 25,964 shares of Obalon Therapeutics Inc (OBLN) as of August 6, 2019, with a value of $79,190 and a weighting of 1.2%.
Latest Holdings of Andrew P Rasdal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DXCM | DexCom Inc | 2006-05-02 | 47,104 | 138.01 | 6,500,823 |
| OBLN | Obalon Therapeutics Inc | 2019-08-06 | 25,964 | 3.05 | 79,190 |
Holding Weightings of Andrew P Rasdal
Andrew P Rasdal Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew P Rasdal has made a total of 0 transactions in DexCom Inc (DXCM) over the past 5 years. The most-recent trade in DexCom Inc is the sale of 2,000,000 shares on May 2, 2006, which brought Andrew P Rasdal around $3 Million.
According to the SEC Form 4 filings, Andrew P Rasdal has made a total of 1 transactions in Obalon Therapeutics Inc (OBLN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Obalon Therapeutics Inc is the acquisition of 4,167 shares on August 6, 2019, which cost Andrew P Rasdal around $50,000.
Insider Trading History of Andrew P Rasdal
- 1
Andrew P Rasdal Trading Performance
GuruFocus tracks the stock performance after each of Andrew P Rasdal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew P Rasdal is -43.38%. GuruFocus also compares Andrew P Rasdal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew P Rasdal within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew P Rasdal's insider trading performs compared to the benchmark.
Performance of Andrew P Rasdal
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.38 | -43.38 | -45.23 | -77.43 | ||
| Relative Return to S&P 500(%) | -46.74 | -50.15 | -61.33 | -93.6 |
Andrew P Rasdal Ownership Network
Ownership Network List of Andrew P Rasdal
Ownership Network Relation of Andrew P Rasdal
Andrew P Rasdal Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Andrew P Rasdal is the director & President & CEO & Exec Chairman of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include Chief Financial Officer Nooshin Hussainy , Chief Technology Officer Mark Brister , and Chief Retail Officer Robert J Macdonald .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Andrew P Rasdal Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew P Rasdal. You might contact Andrew P Rasdal via mailing address: C/o Dexcom, Inc., 5555 Oberlin Drive, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
